Literature DB >> 22005175

Improving osteoporosis care in high-risk home health patients through a high-intensity intervention.

Ryan C Outman1, Jeffrey R Curtis, Julie L Locher, Jeroan J Allison, Kenneth G Saag, Meredith L Kilgore.   

Abstract

PURPOSE: We developed and tested a multi-modal intervention, delivered in the home health care setting, aimed at increasing osteoporosis treatment rates to prevent fractures.
MATERIAL AND METHODS: The intervention focused on home health nurses. Key components included: nursing education; development of a nursing care plan; patient teaching materials and creation of physician materials. Nursing education consisted of a lecture covering osteoporosis, fracture risks and prevention, and the effectiveness of anti-osteoporosis treatment options. Patients received education materials concerning osteoporosis and anti-osteoporosis medications. A pocket-sized treatment algorithm card and standardized order sets were prepared for physicians. Focus groups of physicians and nurses were conducted to obtain feedback on the materials and methods to facilitate effective nurse-physician communication. Successful application required nurses to identify patients with a fracture history, initiate the care plan, prompt physicians on risk status, and provide patient education. The intervention was piloted in one field office.
RESULTS: In the year prior to the intervention, home health patients (n=92) with a fracture history were identified in the pilot field office and only 20 (22%) received osteoporosis prescription therapy. In the three months following the intervention, 21 newly enrolled patients were identified and 9 (43%) had received osteoporosis prescription medications.
CONCLUSIONS: Home health care provides a venue where patients and physicians can be informed by nurses about osteoporosis and fracture risks and, consequently, initiate appropriate therapy. This multi-modal intervention is easily transportable to other home health agencies and adaptable to other medical conditions and settings.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005175      PMCID: PMC4045407          DOI: 10.1016/j.cct.2011.09.020

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  33 in total

1.  Nominal group technique: a process for identifying diabetes self-care issues among patients and caregivers.

Authors:  D Miller; R Shewchuk; T R Elliot; S Richards
Journal:  Diabetes Educ       Date:  2000 Mar-Apr       Impact factor: 2.140

2.  Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group.

Authors:  D M Black; D E Thompson; D C Bauer; K Ensrud; T Musliner; M C Hochberg; M C Nevitt; S Suryawanshi; S R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

3.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

Authors:  C H Chesnut; S Silverman; K Andriano; H Genant; A Gimona; S Harris; D Kiel; M LeBoff; M Maricic; P Miller; C Moniz; M Peacock; P Richardson; N Watts; D Baylink
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

4.  Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

Authors:  J Reginster; H W Minne; O H Sorensen; M Hooper; C Roux; M L Brandi; B Lund; D Ethgen; S Pack; I Roumagnac; R Eastell
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

5.  Postacute care following stroke or hip fracture: single services and combinations used by Medicare beneficiaries (1987-1992).

Authors:  K Berg; O Intrator
Journal:  J Aging Health       Date:  1999-02

Review 6.  Management of osteoporosis among home health and long-term care patients with a prior fracture.

Authors:  Amy H Warriner; Ryan C Outman; Kenneth G Saag; Sarah D Berry; Cathleen Colón-Emeric; Kellie L Flood; Kenneth W Lyles; S Bobo Tanner; Nelson B Watts; Jeffrey R Curtis
Journal:  South Med J       Date:  2009-04       Impact factor: 0.954

7.  Incidence and mortality of hip fractures in the United States.

Authors:  Carmen A Brauer; Marcelo Coca-Perraillon; David M Cutler; Allison B Rosen
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

8.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Authors:  Steven R Cummings; Javier San Martin; Michael R McClung; Ethel S Siris; Richard Eastell; Ian R Reid; Pierre Delmas; Holly B Zoog; Matt Austin; Andrea Wang; Stepan Kutilek; Silvano Adami; Jose Zanchetta; Cesar Libanati; Suresh Siddhanti; Claus Christiansen
Journal:  N Engl J Med       Date:  2009-08-11       Impact factor: 91.245

9.  Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.

Authors:  Catherine MacLean; Sydne Newberry; Margaret Maglione; Maureen McMahon; Veena Ranganath; Marika Suttorp; Walter Mojica; Martha Timmer; Alicia Alexander; Melissa McNamara; Sheetal B Desai; Annie Zhou; Susan Chen; Jason Carter; Carlo Tringale; Di Valentine; Breanne Johnsen; Jennifer Grossman
Journal:  Ann Intern Med       Date:  2007-12-17       Impact factor: 25.391

10.  Zoledronic acid and clinical fractures and mortality after hip fracture.

Authors:  Kenneth W Lyles; Cathleen S Colón-Emeric; Jay S Magaziner; Jonathan D Adachi; Carl F Pieper; Carlos Mautalen; Lars Hyldstrup; Chris Recknor; Lars Nordsletten; Kathy A Moore; Catherine Lavecchia; Jie Zhang; Peter Mesenbrink; Patricia K Hodgson; Ken Abrams; John J Orloff; Zebulun Horowitz; Erik Fink Eriksen; Steven Boonen
Journal:  N Engl J Med       Date:  2007-09-17       Impact factor: 91.245

View more
  5 in total

1.  Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial.

Authors:  Fredric D Wolinsky; Yiyue Lou; Stephanie W Edmonds; Sylvie F Hall; Michael P Jones; Nicole C Wright; Kenneth G Saag; Peter Cram; Douglas W Roblin
Journal:  J Clin Densitom       Date:  2016-09-16       Impact factor: 2.617

2.  Multimodal intervention to improve osteoporosis care in home health settings: results from a cluster randomized trial.

Authors:  M L Kilgore; R Outman; J L Locher; J J Allison; A Mudano; B Kitchin; K G Saag; J R Curtis
Journal:  Osteoporos Int       Date:  2013-03-28       Impact factor: 4.507

3.  Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.

Authors:  Maria I Danila; Ryan C Outman; Elizabeth J Rahn; Amy S Mudano; David T Redden; Peng Li; Jeroan J Allison; Fred A Anderson; Allison Wyman; Susan L Greenspan; Andrea Z LaCroix; Jeri W Nieves; Stuart L Silverman; Ethel S Siris; Nelson B Watts; Michael J Miller; Jeffrey R Curtis; Amy H Warriner; Nicole C Wright; Kenneth G Saag
Journal:  J Bone Miner Res       Date:  2018-02-26       Impact factor: 6.741

4.  Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.

Authors:  P Cram; F D Wolinsky; Y Lou; S W Edmonds; S F Hall; D W Roblin; N C Wright; M P Jones; K G Saag
Journal:  Osteoporos Int       Date:  2016-06-30       Impact factor: 4.507

5.  A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material.

Authors:  Maria I Danila; Ryan C Outman; Elizabeth J Rahn; Amy S Mudano; Tammi F Thomas; David T Redden; Jeroan J Allison; Fred A Anderson; Julia P Anderson; Peter M Cram; Jeffrey R Curtis; Liana Fraenkel; Susan L Greenspan; Andrea Z LaCroix; Sumit R Majumdar; Michael J Miller; Jeri W Nieves; Monika M Safford; Stuart L Silverman; Ethel S Siris; Daniel H Solomon; Amy H Warriner; Nelson B Watts; Robert A Yood; Kenneth G Saag
Journal:  Contemp Clin Trials Commun       Date:  2016-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.